Xalatan, Latanoprost News

Novagali Pharma, a French pharmaceutical ophthalmic company, announces today that the Company's Investigational New Drug Application to conduct a Phase III clinical trial of Catioprost , for the treatment of glaucoma has been granted by the U.S. Food and Drug Administration .

NicOx S.A. today announced that four scientific posters on PF‑03187207 for glaucoma were presented yesterday by NicOx and Pfizer at the Association for Research in Vision and Ophthalmology Annual Meeting in Fort Lauderdale, Florida.

Here are the latest clinical trials, courtesy of ClinicalConnection.com and CenterWatch : Osteoarthritis of the Knee or Hip If you have osteoarthritis of the knee or hip, you may qualify for this study.

Farming is in the blood of many producers, but as much as they love it, they often supplement their income with other jobs.

Bimatoprost showed greater effi-cacy in lowering intraocular pressure when compared to other prostaglandin analogs latanoprost and travoprost, according to a new meta-analysis. Clinical trials published up to July 2006 were used for the study, with the inclusion criteria being prospective, randomized, controlled clinical trials; patients with ...

Here are the latest clinical trials, courtesy of CenterWatch : Ocular Hypertension If you have been diagnosed with ocular hypertension or open angle glaucoma and are currently using Xalatan eye drops, you may qualify for this study.

Pfizer is teaming up with eye-care specialist Bausch & Lomb to promote both companies' prescription eye drugs.

NEW YORK & ROCHESTER, N.Y. - Pfizer Inc and Bausch & Lomb announced today a co-promotion agreement involving both companies' prescription ophthalmic pharmaceuticals in the United States.

Main Category: Eye Health / Blindness Also Included In: Pharma Industry / Biotech Industry Article Date: 28 Feb 2009 Novagali Pharma, a French pharmaceutical ophthalmic company, announced the results of its ...

I'I I'IsIYI I I©I I- I I I IYI -PRN-Novagali Pharma. Novagali Pharma Presents Results of its Innovative Latanoprost Formulation for Glaucoma EVRY, France, February 27/PRNewswire/ -- Novagali Pharma, a ...